Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial
Germany: In patients with heart failure, hyperuricemia is a common comorbidity and is an independent predictor of advanced disease severity and increased mortality, the researchers' state in a study...
Source: medicaldialogues.in